Genzyme CorporateResearchSearchGenzyme Websites
Patients and FamiliesHeath Care Professionals

Patients and Families
Chronic Kidney Disease
Treatments
Related Links

Access to Renvela

Genzyme has an on-going commitment to help provide access to Renvela® (sevelamer carbonate).

While many of you may have prescription benefits, for those of you who do not or whose prescription benefits are limited or require prior authorization, getting prescription drugs may be a challenge. To help you, Genzyme RenassistSM offers a variety of services that may make Renvela more accessible. Our dedicated team of Renassist Case Managers make the process easy. They can work with your social worker, dietitian or patient advocate to determine the type of assistance you need.

Your Renassist Case Manager along with your Social Worker can:

  • Verify your insurance coverage
  • Facilitate any prior authorizations
  • Research coverage of Renvela within specific plans
  • Educate you on Medicare Part D and other changes to Medicare
  • Submit your application to the American Kidney Fund to determine free-drug eligibility

These services are offered at no cost. Case Managers act in accordance with patient privacy regulations (HIPAA) to maintain patient confidentiality.

With just one phone call, Genzyme can help you gain access to Renvela. Talk to your social worker today.


Genzyme Renvela

Important Treatment Considerations

Renvela® (sevelamer carbonate) is used to control phosphorus levels in patients with chronic kidney disease (CKD) on dialysis

  • Do not use Renvela if you have a history of bowel obstruction
  • Talk to your doctor if you have had digestive tract surgery or other digestive disorders, including severe constipation
  • Uncommon cases of bowel obstruction and perforation have been reported
  • Your doctor should monitor bicarbonate and chloride blood levels • Vitamins D, E, K (clotting factors), and folic acid blood levels should also be monitored by your doctor
  • The most frequently occurring side effects observed with sevelamer carbonate tablets were nausea and vomiting
  • Side effects with sevelamer carbonate powder taken three times a day were similar to those reported for sevelamer carbonate tablets
  • The most common side effects with sevelamer hydrochloride, which contains the same active ingredient as sevelamer carbonate, included: vomiting, nausea, diarrhea, dyspepsia, abdominal pain, flatulence, and constipation
  • Cases of fecal impaction and, less commonly, ileus, bowel obstruction, and bowel perforation have been reported
  • Take Renvela with meals and adhere to your prescribed diet
  • Talk to your doctor when taking Renvela with other medications • Promptly contact your doctor if you experience severe abdominal pain, new or worsening constipation, or other severe intestinal symptoms while on Renvela

Please see accompanying full Prescribing Information.


Genzyme Renvela

Learn how the Renassist team can help patients access Renvela.
Go to the Renassist Website >

Contact
Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142
T: 800 847 0069
F: 617 252 7600

Email Us
© 2010 Genzyme Corporation | Terms and Conditions of Use | Privacy Policy